Triple-negative breast cancer (TNBC) is characterized by the lack expression of estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor type 2 (HER2); these tumors are more invasive and metastatic, and therefore treatments are more unspecific and aggressive (chemotherapy). Recently, it has been proposed the possibility...
